Yiwei Shen

机构：Shanghai Jiao Tong University, Renji Hospital, Shanghai Ninth People's Hospital, Tianjin Fourth Hospital · ORCID：0000-0003-4594-5035

发表论文 37 篇 · 总被引 433 次 · h-index 11

代表论文

• The transcription factor ZEB2 drives the formation of age-associated B cells (2024 · Science · 被引 158)
• Dihydroartemisinin, a potential PTGS1 inhibitor, potentiated cisplatin-induced cell death in non-small cell lung cancer through activating ROS-mediated multiple signaling pathways (2024 · Neoplasia · 被引 25)
• Biomarkers for systemic lupus erythematosus – a focus on organ damage (2023 · Expert Review of Clinical Immunology · 被引 17)
• Assessing renal interstitial fibrosis using compartmental, non-compartmental, and model-free diffusion MRI approaches (2024 · Insights into Imaging · 被引 16)
• Polydatin, a potential NOX5 agonist, synergistically enhances antitumor activity of cisplatin by stimulating oxidative stress in non‑small cell lung cancer (2024 · International Journal of Oncology · 被引 13)
• Dihydrotanshinone I potentiates the anti-tumor activity of cisplatin by activating ROS-mediated ER stress through targeting HSPD1 in lung cancer cells (2025 · European Journal of Pharmacology · 被引 9)